genOway S.A.
ALGEN.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | €36 | €42 | €35 | €38 |
| - Cash | €5 | €4 | €5 | €6 |
| + Debt | €6 | €7 | €9 | €11 |
| Enterprise Value | €36 | €44 | €39 | €43 |
| Revenue | €22 | €20 | €17 | €14 |
| % Growth | 10% | 17.6% | 21.6% | – |
| Gross Profit | -€2 | €19 | -€1 | -€4 |
| % Margin | -8.5% | 93.8% | -7.7% | -26.7% |
| EBITDA | €4 | €6 | €1 | -€2 |
| % Margin | 17.7% | 31.7% | 3.1% | -13.4% |
| Net Income | €2 | €2 | €1 | -€0 |
| % Margin | 8.3% | 7.8% | 4.6% | -2.3% |
| EPS Diluted | 0.2 | 0.17 | 0.088 | -0.037 |
| % Growth | 17.6% | 92.7% | 341% | – |
| Operating Cash Flow | €5 | €3 | €2 | -€1 |
| Capital Expenditures | -€2 | -€2 | -€2 | -€2 |
| Free Cash Flow | €3 | €1 | €0 | -€3 |